期刊文献+

乙型脑炎病毒E蛋白HLA—A*0201限制性细胞毒性T细胞表位的预测

Prediction of the HLA2-restricted CTL epitopes derived from the Japanese encephalitis virus envelope protein
在线阅读 下载PDF
导出
摘要 目的:预测乙型脑炎病毒E蛋白(Japanese encephalitis virus envelope protein,JEVE蛋白)的HLAA2限制性CTL表位。方法:采用SYFPEITHI超基序法、量化基序多项式方案分析及延展基序方案联合应用,筛选JEVE蛋白HLA-A2限制性的九肽细胞毒性T淋巴细胞(cytotoxic lymphocyte,CTL)表位。结果:通过预测获得了9个JEVE蛋白HLA-A0201限制性的九肽CTL表位。结论:超基序法与量化基序多项式方案分析及延展基序方案的联合应用所产生的JEVE蛋白CTL表位,为进一步研制新型乙脑肽疫苗奠定了重要的基础。 Objective :To predict the HLA - A * 0201 restricted CTL epitopes of Japanese encephalitis virus envelope (JEV E) protein. Methods: HLA - A * 0201 restricted CTL epitopes of JEV E protein was predicted by the combined application of SYFPEITHI supermotif prediction, quantitative motif and extended motifs. Results: Nine HLA - A * 0201 restricted CTL epitope candidates derived from JEV E protein were selected. Conclusion: The JEV E protein CTL epitopes generated by the combined application of SYFPE1THI supermotif prediction, quantitative motif and extended motifs laid an important foundation to further develop the new type of JEV peptide vaccine.
出处 《现代肿瘤医学》 CAS 2009年第6期1046-1048,共3页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(30400167) 陕西省科技计划项目[2007K09-05(2)]
关键词 日本脑炎病毒E蛋白 细胞毒性T淋巴细胞表位 预测 JEV E protein cytotoxic T lymphocyte epitope prediction
  • 相关文献

参考文献12

  • 1王子周.成人重型乙脑非典型发病1例报告[J].中国人兽共患病杂志,2000,16(4):40-40. 被引量:6
  • 2董海龙,隋延仿.肝癌相关肿瘤抗原HLA-A2限制性CTL表位的预测[J].第四军医大学学报,2003,24(6):492-494. 被引量:7
  • 3Gulukota K,Sidney J,Sette A,et al.Two complementary methods for predicting peptides binding major histocompatibility complex molecules[J].J Mol Biol,1997,267(5):1258-1267.
  • 4Chen YH,Xiao Y,Yu T,et al.Epitope vaccine:a new strategy against HIV-1[J].Immunology Today,1999,20(12):588-589.
  • 5Tarr AW,Owsianka AM,Timms JM,et al.Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33[J].Hepatology,2006,43(3):592-601.
  • 6Engler OB,Schwendener RA,Dai WJ,et al.A liposomal peptide vaccine inducing CD8^+ T cells in HLA-A2.1 transgenic mice,which recognise human cells encoding hepatitis C virus (HCV) proteins[J].Vaccine,2004,23(1):58-68.
  • 7E1Kasmi KC,Theisen D,Brons NH,et al.A hemagglutinin-derived peptide-vaccine ignored by virus-neutralizing passive antibodies,protects against murine measles encephalitis[J].Vaccine,1999,17(19):2436-2445.
  • 8Muderspach L,Wilczynski S,Roman L,et al.A phase Ⅰ trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive[J].Clin Cancer Res,2000,6(9):3406-3416.
  • 9Mason PW,Dalrymple JM,Gentry MK,et al.Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein[J].J Gen Virol,1989,70(Pt8):2037-2049.
  • 10Srivastava AK,Morita K,Matsuo S,et al.Japanese encephalitis virus fusion protein with protein A expressed in Escherichia coli confers protective immunity in mice[J].Microbiol Immunol,1991,35(10):863-870.

二级参考文献11

  • 1乔汉臣,实用传染病学,1994年,135页
  • 2李梦东,实用传染病学,1994年,135页
  • 3Bai X F,第四军医大学学报,2000年,21卷,7期,850页
  • 4Yang Q X,细胞与分子免疫学杂志,2000年,16卷,6期,464页
  • 5Bai X F,第四军医大学学报,1998年,19卷,6期,709页
  • 6Du Y,国外医学.免疫学分册,1998年,21卷,2期,103页
  • 7Zhang M J,Acta Virol,1992年,36卷,6期,533页
  • 8Ma W Y,第四军医大学学报,1984年,5卷,4期,251页
  • 9Navapun Charuruks,Pisit Tangkijvanich,Narin Voravud,Ratana Chatsantikul,Apiradee Theamboonlers,Yong Poovorawan. Clinical significance of p53 antigen and anti-p53 antibodies in the sera of hepatocellular carcinoma patients[J] 2001,Journal of Gastroenterology(12):830~836
  • 10Nicolina Renkvist,Chiara Castelli,Paul F. Robbins,Giorgio Parmiani. A listing of human tumor antigens recognized by T cells[J] 2001,Cancer Immunology, Immunotherapy(1):3~15

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部